G. Hobe

No ORCID on file · 14 papers in corpus
article 2001

Dienogest (17 alpha-cyanomethyl-17-hydroxy-4,9-estradien-3-one) is the progestagen component of the oral contraceptives Certostat and Valette. In contrast to other 19-norsteroid progestagens like levonorgestrel, norethisterone, gestodene an…

article 1998
·doi:10.1016/s0039-128x(98)00014-2

The biotransformation of the progestagen dienogest (17 alpha-cyanomethyl-17 beta-hydroxy-4,9-estradien-3-one) was studied in vivo in female rabbits and in vitro by liver homogenates from female rabbits and rats. In vivo, in the female rabbi…

article 1998
book-chapter 1995
·doi:10.1515/9783112422168-010
book-chapter 1995
·doi:10.1515/9783110813210-010
article 1995
·doi:10.1515/9783112422168-011
book-chapter 1995
·doi:10.1515/9783110813210-011
book-chapter 1995
·doi:10.1515/9783112422168-012
book-chapter 1995
·doi:10.1515/9783110813210-012
book-chapter 1995
·doi:10.1515/9783110813210-007
book-chapter 1995
·doi:10.1515/9783112422168-007
book-chapter 1995
·doi:10.1515/9783112422168-006
article 1986

For the radioimmunological determination (RIA) of the progestagen dienogest (1, 17 alpha-Cyanomethyl-17 beta-hydroxy-estra-4,9-dien-3-one) in plasma three methods of sample preparation were tested and compared: Extraction of plasma samples …

article 1986

Following oral administration of 2 mg of dienogest (17 alpha-cyanomethyl-17 beta-hydroxy-4,9-estradien-3-one) to female volunteers, the dienogest concentration courses in plasma and saliva were determined by means of a specific radioimmunoa…